Yulu Dai

Title: Yulu Dai - Innovator in Insulin Derivatives

Introduction

Yulu Dai is a prominent inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of insulin derivatives. His innovative work focuses on improving the efficacy and stability of insulin treatments for diabetes.

Latest Patents

Yulu Dai holds a patent for an acylated derivative of human insulin or an analogue thereof. This patent describes an acylated derivative of a human insulin analogue, specifically the Des(B30) human insulin. The acylated derivative is noted for being longer-lasting than existing insulin analogues, providing a more stable blood glucose reduction and enhanced storage stability.

Career Highlights

Yulu Dai is associated with Jiangsu Hengrui Medicine Company Ltd., where he continues to advance his research and development efforts. His work has the potential to significantly impact diabetes management and improve the quality of life for patients.

Collaborations

Yulu Dai collaborates with talented colleagues, including Tao Wang and Feifei Wang, who contribute to his research initiatives and help drive innovation within the company.

Conclusion

Yulu Dai's contributions to the field of insulin derivatives exemplify the importance of innovation in healthcare. His work not only enhances the effectiveness of diabetes treatments but also showcases the potential for advancements in pharmaceutical science.